• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[供体T细胞Stat3缺陷对小鼠急性肠道移植物抗宿主病的影响]

[Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice].

作者信息

Xu Y X, Wang X Q, Yang S J, Song Q X, Wei J, Zhang X

机构信息

Department of Hematology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637002, China Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Blood Ecology and Smart Cell Science Innovation Center, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China Jinfeng Laboratory, Chongqing 401329, China.

Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Blood Ecology and Smart Cell Science Innovation Center, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing 400037, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):302-313. doi: 10.3760/cma.j.cn121090-20250107-00011.

DOI:10.3760/cma.j.cn121090-20250107-00011
PMID:40425451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12158802/
Abstract

To investigate the effects and underlying mechanisms of Stat3 knockout in donor T cells on acute gastrointestinal graft-versus-host disease (GI-aGVHD) . BALB/c mice were exposed to lethal irradiation and transplanted with bone marrow and spleen cells from BALB/c mice (syngeneic control group), C57BL/6 mice (wild-type T cell group, WT group), or C57BL/6J-Stat3(em1cyagen) mice (Stat3 gene knockout T cell group, Stat3-KO group) via tail vein injection to establish the aGVHD model. The survival rate, body weight changes, and clinical scores of mice were monitored. Cytometric bead array (CBA) was used to detect the concentrations of serum cytokines. Lymphocytes were isolated from tissues for flow cytometric analysis. H&E staining was performed to observe intestinal pathological changes. FITC-dextran assay was conducted to assess intestinal permeability. Immunohistochemistry was used to evaluate the expression of Ki67 and Muc2. Real-Time Quantitative Reverse Transcription PCR (qRT-PCR) was employed to analyze the gene expression levels of Olfm4, Lysozyme, and Muc2 in the small intestine. Metabolomics was conducted to detect metabolites in serum and intestinal tissues. An in vitro GI-aGVHD organoid model was established by coculturing intestinal organoids with allogeneic T cells, where the number and area of small intestinal organoids were recorded. The GVL effect was assessed using luciferase-transfected ALL cells (ALL/Luc) and bioluminescent imaging. Compared with the WT group, Stat3 knockout T cells alleviated body weight loss, reduced symptoms-such as hunchback and diarrhea-in mice, improved survival rate (<0.05), and reduced serum interleukin (IL) -2, IL-6, interferon-γ, tumor necrosis factor-α, IL-17A, and IL-10 levels (all <0.05), intestinal inflammatory cell infiltration (<0.05), and intestinal mucosal permeability. Further, Muc2 and Ki67 expression levels in the small intestine of the Stat3 knockout group were markedly increased, and Olfm4, Lysozyme, and Muc2 gene expression levels were significantly increased (all <0.05). In vitro, the Stat3 knockout group demonstrated better organoid development than the WT group. Metabolomic analyses indicated that Stat3 knockout in T cells may affect the pathways associated with bile acid secretion and unsaturated fatty acids. ALL/Luc cells in the GVL mouse model proliferated rapidly in the TCD-BM group; however, 80% of the mice in the Stat3-KO group survived tumor-free for >100 days (<0.05) . Knocking out Stat3 in graft T cells reduces T cell damage to intestinal stem cells, thereby ultimately alleviating GI-aGVHD while maintaining a stable GVL effect.

摘要

为研究供体T细胞中Stat3基因敲除对急性胃肠道移植物抗宿主病(GI-aGVHD)的影响及潜在机制。将BALB/c小鼠进行致死性照射,然后通过尾静脉注射来自BALB/c小鼠的骨髓和脾细胞(同基因对照组)、C57BL/6小鼠的骨髓和脾细胞(野生型T细胞组,WT组)或C57BL/6J-Stat3(em1cyagen)小鼠的骨髓和脾细胞(Stat3基因敲除T细胞组,Stat3-KO组),以建立aGVHD模型。监测小鼠的存活率、体重变化和临床评分。采用细胞因子微球阵列(CBA)检测血清细胞因子浓度。从组织中分离淋巴细胞进行流式细胞术分析。进行苏木精-伊红(H&E)染色以观察肠道病理变化。进行异硫氰酸荧光素-葡聚糖(FITC-葡聚糖)检测以评估肠道通透性。采用免疫组织化学评估Ki67和Muc2的表达。运用实时定量逆转录聚合酶链反应(qRT-PCR)分析小肠中Olfm4、溶菌酶和Muc2的基因表达水平。进行代谢组学检测血清和肠道组织中的代谢物。通过将肠道类器官与同种异体T细胞共培养建立体外GI-aGVHD类器官模型,记录小肠类器官的数量和面积。使用荧光素酶转染的急性淋巴细胞白血病(ALL)细胞(ALL/Luc)和生物发光成像评估移植物抗白血病(GVL)效应。与WT组相比,Stat3基因敲除T细胞减轻了小鼠体重减轻,减少了如驼背和腹泻等症状,提高了存活率(<0.05),并降低了血清白细胞介素(IL)-2、IL-6、干扰素-γ、肿瘤坏死因子-α、IL-17A和IL-10水平(均<0.05)、肠道炎性细胞浸润(<0.05)以及肠道黏膜通透性。此外,Stat3基因敲除组小肠中Muc2和Ki67的表达水平显著升高,Olfm4、溶菌酶和Muc2的基因表达水平也显著增加(均<0.05)。在体外,Stat3基因敲除组的类器官发育优于WT组。代谢组学分析表明,T细胞中Stat3基因敲除可能影响与胆汁酸分泌和不饱和脂肪酸相关的途径。GVL小鼠模型中的ALL/Luc细胞在去除T细胞的骨髓(TCD-BM)组中迅速增殖;然而,Stat3-KO组中80%的小鼠无瘤存活>100天(<0.05)。敲除移植物T细胞中的Stat3可减少T细胞对肠道干细胞的损伤,从而最终减轻GI-aGVHD,同时维持稳定的GVL效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/62ddc80bd1a1/cjh-46-04-302-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/5413a9a85ead/cjh-46-04-302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/29c62f8f8ef8/cjh-46-04-302-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/2038b8bee95e/cjh-46-04-302-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/d06f328015e1/cjh-46-04-302-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/b743bd264d30/cjh-46-04-302-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/eb6c34ca1175/cjh-46-04-302-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/dbd26d9fbc59/cjh-46-04-302-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/62ddc80bd1a1/cjh-46-04-302-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/5413a9a85ead/cjh-46-04-302-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/29c62f8f8ef8/cjh-46-04-302-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/2038b8bee95e/cjh-46-04-302-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/d06f328015e1/cjh-46-04-302-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/b743bd264d30/cjh-46-04-302-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/eb6c34ca1175/cjh-46-04-302-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/dbd26d9fbc59/cjh-46-04-302-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/200f/12158802/62ddc80bd1a1/cjh-46-04-302-g008.jpg

相似文献

1
[Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice].[供体T细胞Stat3缺陷对小鼠急性肠道移植物抗宿主病的影响]
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):302-313. doi: 10.3760/cma.j.cn121090-20250107-00011.
2
[Establishment and Evaluation of Intestinal Injury Model of Mouse Acute Graft Versus Host Disease Based on An Organoid Technology].基于类器官技术的小鼠急性移植物抗宿主病肠道损伤模型的建立与评价
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):233-240. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.037.
3
Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells.间充质干细胞外泌体来源的 miR-223 通过减少供体 T 细胞的迁移来缓解急性移植物抗宿主病。
Stem Cell Res Ther. 2021 Feb 26;12(1):153. doi: 10.1186/s13287-021-02159-2.
4
Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.骨桥蛋白通过防止肠上皮细胞凋亡来减轻急性胃肠道移植物抗宿主病。
Biochem Biophys Res Commun. 2017 Apr 1;485(2):468-475. doi: 10.1016/j.bbrc.2017.02.047. Epub 2017 Feb 9.
5
[Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].[基因修饰表达sTNFR I的未成熟树突状细胞对异基因骨髓移植小鼠移植物抗宿主病(GVHD)和移植物抗白血病(GVL)的影响]
Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):88-93.
6
Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.葫芦素 E 通过调节 Th17 细胞亚群和抑制 STAT3 激活来改善急性移植物抗宿主病。
Immunol Lett. 2018 Nov;203:62-69. doi: 10.1016/j.imlet.2018.09.012. Epub 2018 Sep 18.
7
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.供体白细胞介素-22和宿主I型干扰素信号通路通过STAT1激活和CXCL10参与肠道移植物抗宿主病。
Mucosal Immunol. 2016 Mar;9(2):309-21. doi: 10.1038/mi.2015.61. Epub 2015 Jul 8.
8
[Establishment and Evaluation Strategy of an Cell Model of Bone Marrow Microenvironment Injury in Mouse Acute Graft-Versus-Host Disease].[小鼠急性移植物抗宿主病骨髓微环境损伤细胞模型的建立及评价策略]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):617-624. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.044.
9
Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation.淫羊藿苷可预防急性移植物抗宿主病,同时在异基因造血干细胞移植后保留移植物抗白血病活性。
Phytomedicine. 2024 Sep;132:155901. doi: 10.1016/j.phymed.2024.155901. Epub 2024 Jul 18.
10
[Establishment and Application of an in Vitro Cellular Model of Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells with Serum Injury in aGVHD Mouse].[建立并应用急性移植物抗宿主病小鼠血清损伤骨髓间充质干细胞成脂分化的体外细胞模型]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2025 Feb;33(1):255-261. doi: 10.19746/j.cnki.issn.1009-2137.2025.01.038.

本文引用的文献

1
STAT1 regulates immune-mediated intestinal stem cell proliferation and epithelial regeneration.信号转导和转录激活因子1(STAT1)调节免疫介导的肠道干细胞增殖和上皮再生。
Nat Commun. 2025 Jan 2;16(1):138. doi: 10.1038/s41467-024-55227-5.
2
The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8 T cells against cancer.2 型细胞因子 Fc-IL-4 可使衰竭的 CD8 T 细胞重新对癌症产生反应。
Nature. 2024 Oct;634(8034):712-720. doi: 10.1038/s41586-024-07962-4. Epub 2024 Sep 25.
3
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission.
单细胞 CAR T 图谱揭示 8 年白血病缓解中的 2 型功能。
Nature. 2024 Oct;634(8034):702-711. doi: 10.1038/s41586-024-07762-w. Epub 2024 Sep 25.
4
Inflammation-induced epigenetic imprinting regulates intestinal stem cells.炎症诱导的表观遗传印记调控肠道干细胞。
Cell Stem Cell. 2024 Oct 3;31(10):1447-1464.e6. doi: 10.1016/j.stem.2024.08.006. Epub 2024 Sep 3.
5
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease.微生物胆汁酸代谢改变加剧移植物抗宿主病中的 T 细胞驱动的炎症。
Nat Microbiol. 2024 Mar;9(3):614-630. doi: 10.1038/s41564-024-01617-w. Epub 2024 Mar 1.
6
Novel T cell/organoid culture system allows modeling of intestinal graft-versus-host disease.新型 T 细胞/类器官培养系统可模拟肠道移植物抗宿主病。
Front Immunol. 2023 Aug 29;14:1253514. doi: 10.3389/fimmu.2023.1253514. eCollection 2023.
7
Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity.供体 T 细胞 STAT3 缺陷使组织 PD-L1 依赖性预防移植物抗宿主病,同时保留移植物抗白血病活性。
J Clin Invest. 2023 Aug 1;133(15):e165723. doi: 10.1172/JCI165723.
8
Acute graft-versus-host disease.急性移植物抗宿主病。
Nat Rev Dis Primers. 2023 Jun 8;9(1):27. doi: 10.1038/s41572-023-00438-1.
9
[Establishment and Evaluation of Intestinal Injury Model of Mouse Acute Graft Versus Host Disease Based on An Organoid Technology].基于类器官技术的小鼠急性移植物抗宿主病肠道损伤模型的建立与评价
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):233-240. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.037.
10
Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.近期代谢进展在预防和治疗急、慢性移植物抗宿主病中的作用
Front Immunol. 2021 Oct 12;12:757836. doi: 10.3389/fimmu.2021.757836. eCollection 2021.